<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01973530</url>
  </required_header>
  <id_info>
    <org_study_id>BHJRC_HK_TKR_Study_2014</org_study_id>
    <nct_id>NCT01973530</nct_id>
  </id_info>
  <brief_title>Comparison of Femoral Nerve Catheter and Adductor Canal Block With Steroid Adjuvant in Total Knee Replacement (TKR)</brief_title>
  <official_title>Comparison of the Analgesic Efficacy of Continuous Femoral Nerve Block and Adductor Canal Block With Steroid Adjuvant in Patients Undergoing Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen Elizabeth Hospital, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen Elizabeth Hospital, Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize continuous adductor canal block with steroid adjuvant would offer no inferior
      analgesics and rehabilitation ability than continuous femoral nerve block for postoperative
      patients receiving total knee arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 80 patients who will undergo total knee arthroplasty will be randomized into two
      groups:

      Treatment groups Treatment details Femoral Group (40 patients) Continuous femoral nerve block
      (bolus: 0.5% Ropivacaine 10-15 ml ; infusion of 0.15 % Ropivacaine 4-6ml/h) Adductor Group
      (40 patients) Adductor canal block with steroid adjuvant (bolus: 0.5% Ropivacaine 10-15ml;
      Dexamethasone 4mg) (Total 80 patients will be recruited)

        -  All patients will receive single shot tibial nerve block with local anaesthetics (0.5%
           Ropivacaine 5-8ml) before surgery for analgesia of posterior knee.

        -  All patients will receive the same preemptive and postoperative multimodal medications
           for perioperative analgesia.

        -  All groups will receive standardized method of spinal anaesthesia and standardized
           method of intraoperative sedation for the surgery.

        -  Intravenous patient controlled analgesia (PCA) with morphine will be given for 48h to
           patient as rescue analgesia.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PCA morphine or pain rescuer consumption at 24h and 48h postoperative</measure>
    <time_frame>24h and 48h postoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain score (visual analogue scale 0-10) at 6h,12h, 24h,48h, 72h after surgery</measure>
    <time_frame>6h,12h, 24h,48h, 72h after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Quadriceps strength at 24h, 48h, 72h postoperative</measure>
    <time_frame>24h, 48h, 72h postoperative</time_frame>
    <description>using dynamometer (measure in Newton/centimeter square)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score (0-4)</measure>
    <time_frame>upon discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of side effects and complications at postoperative day 0- 4 postoperative</measure>
    <time_frame>postoperative period 0-96 hr postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay in hospital 6. Length of Stay in hospital length of hospital stay</measure>
    <time_frame>upon discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative nausea or vomiting</measure>
    <time_frame>0-72h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pruritis</measure>
    <time_frame>0-72h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemastix on call and every 8 hours after surgery for postoperative 24hours for patients</measure>
    <time_frame>on call and every 8 hours after surgery for postoperative 24h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>adductor canal block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous adductor canal block and single shot posterior tibial nerve block under ultrasound guidance and using nerve stimulating needle (bolus: 0.5% Ropivacaine 10-15ml with dexamethasone 4mg ;with single shot posterior tibial nerve block (8-10ml 0.5% ropivacaine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>continuous femoral nerve block</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Femoral nerve catheter inserted under ultrasound guidance using nerve stimulating needle administering ropivacaine bolus 10-15ml and infusing 0.2% ropivacaine at 4-6ml/h; plus a single shot posterior tibial nerve block under ultrasound guidance and use of nerve stimulating needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>adductor canal block</intervention_name>
    <description>Continuous adductor canal block and single shot posterior tibial nerve block under ultrasound guidance and using nerve stimulating needle (bolus: 0.5% Ropivacaine 10-15ml with dexamethasone 4mg ;with single shot posterior tibial nerve block (8-10ml 0.5% ropivacaine)</description>
    <arm_group_label>adductor canal block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>femoral nerve block</intervention_name>
    <description>Femoral nerve catheter inserted under ultrasound guidance using nerve stimulating needle administering ropivacaine bolus 10-15ml and infusing 0.2% ropivacaine at 4-6ml/h; plus a single shot posterior tibial nerve block under ultrasound guidance and use of nerve stimulating needle</description>
    <arm_group_label>continuous femoral nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of primary osteoarthritis

          -  Scheduled for elective total knee arthroplasty

          -  Signed written informed consent

          -  Planned use of spinal anaesthesia

          -  Cognitive sound to use assessment tools

        Exclusion Criteria:

          -  Patients refusing to give consents

          -  Scheduled for revision total knee replacement

          -  Patient outside range of 30 to 80 yrs old

          -  Non-chinese population

          -  Cognitive impairment/ inability to use the outcome assessment tools

          -  Contraindications to regional anesthesia

          -  severe cardiovascular disease (unstable angina, second or third degree heart block)

          -  pre-existing neurologic disease including psychiatric disorder

          -  drug abuser

          -  Pre-operative history of neurological abnormality in the ipsilateral leg e.g. history
             of stroke, neurogenic pain or previous nerve injury.

          -  Allergy or contraindication to drugs used in this study: morphine, Non-steroidal
             anti-inflammatory drugs (NSAID) such as ketorolac , diclofenac, dihydrocodeine, local
             anaesthetics (lignocaine, ropivacaine, bupivacaine), epinephrine

          -  Moderate or severe renal impairment (serum creatinine &gt; 160 micromol/l)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric So, FHKCA FHKAM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen Elizabeth Hospital, Hospital Authority</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric So, FHKCA FHKAM</last_name>
    <phone>29588888</phone>
    <email>sohke@ha.org.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Joint Replacement Center, Buddhist Hospital</name>
      <address>
        <city>Kowloon</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric So, FHKCA FHKAM</last_name>
      <phone>29588888</phone>
      <phone_ext>6202</phone_ext>
      <email>sohke@ha.org.hk</email>
    </contact>
    <investigator>
      <last_name>Vincent Ho, FANZCA FHKCA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wai Hong Yuen, FHKCOS FHKAM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Wong, FHKCOS FHKAM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Chong, FHKCA FHKAM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric So, FHKCA FHKAM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Loretta Leung, FHKCA FHKAM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dennis Wan, FHKCA FHKAM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grace Hui, FHKCA FHKAM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2013</study_first_submitted>
  <study_first_submitted_qc>October 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2013</study_first_posted>
  <last_update_submitted>September 8, 2014</last_update_submitted>
  <last_update_submitted_qc>September 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen Elizabeth Hospital, Hong Kong</investigator_affiliation>
    <investigator_full_name>Dr Hui Kit Man Grace</investigator_full_name>
    <investigator_title>Associate Consultant, Dept of Anaesthesia and Operating Services</investigator_title>
  </responsible_party>
  <keyword>femoral nerve block</keyword>
  <keyword>adductor canal block</keyword>
  <keyword>steroid</keyword>
  <keyword>total knee replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

